|
Real-time Estimate
Cboe Europe
05:41:37 20/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 12,488.00 GBX | +0.71% |
|
+5.09% | -9.35% |
| 04:40pm | AstraZeneca PLC : Jefferies keeps its Buy rating | ZD |
| 04:05pm | AstraZeneca and Oracle partner to advance AI in clinical trials | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 26TCr | |||||
| 1,10600Cr | |||||
| 61TCr | |||||
| 50TCr | |||||
| 37TCr | |||||
| 35TCr |
- Stock Market
- Stocks
- AZN Stock
- Charts AstraZeneca PLC
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
